$0.67
-0.01 (-1.47%)
Emisphere Technologies, Inc. (EMIS)
CAPS Rating:
A biopharmaceutical company specializing in the oral delivery of therapeutic macromolecules and other compounds that are poorly deliverable by oral means.

RSS Headlines
Fool UK